News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
771 Results
Type
Article (191)
Press Release (580)
Section
Business (342)
Career Advice (5)
Deals (8)
Drug Delivery (10)
Drug Development (18)
Employer Resources (1)
FDA (6)
Job Trends (41)
News (483)
Policy (177)
Tag
Academia (4)
Adcomms (1)
Alliances (23)
Alzheimer's disease (5)
Antibody-drug conjugate (ADC) (1)
Approvals (5)
Bankruptcy (1)
Best Places to Work (30)
BIOSECURE Act (1)
Biosimilars (1)
Cancer (1)
Career advice (5)
Clinical research (6)
COVID-19 (3)
Diagnostics (3)
Drug pricing (23)
Earnings (10)
Editorial (2)
Employer resources (1)
Events (100)
Executive appointments (2)
FDA (7)
Friedreich's ataxia (1)
GLP-1 (4)
Government (81)
Healthcare (21)
Infectious disease (3)
Inflation Reduction Act (2)
IPO (3)
IRA (15)
Job creations (11)
Job search strategy (5)
Layoffs (1)
Legal (55)
Management (1)
Manufacturing (1)
Medical device (3)
Medtech (3)
Mergers & acquisitions (4)
Metabolic disorders (1)
Neuroscience (6)
NextGen: Class of 2025 (13)
Non-profit (14)
Obesity (1)
Opinion (11)
Patents (1)
People (289)
Pharmacy benefit managers (2)
Phase I (2)
Phase II (3)
Phase III (5)
Policy (17)
Postmarket research (1)
Preclinical (2)
Rare diseases (1)
Regulatory (53)
Research institute (4)
Schizophrenia (1)
Special edition (1)
Startups (2)
Tariffs (2)
The Weekly (1)
Vaccines (1)
Weight loss (1)
Date
Last 7 days (2)
Last 30 days (4)
Last 365 days (27)
2025 (7)
2024 (42)
2023 (51)
2022 (30)
2021 (46)
2020 (70)
2019 (95)
2018 (51)
2017 (62)
2016 (66)
2015 (37)
2014 (40)
2013 (26)
2012 (21)
2011 (21)
2010 (18)
Location
Africa (3)
Asia (24)
Australia (3)
California (2)
Europe (46)
Illinois (2)
Indiana (1)
Massachusetts (3)
New York (1)
Northern California (1)
South America (3)
Southern California (1)
Texas (1)
United States (12)
Washington D.C. (2)
771 Results for "phrma".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Podcast
Novo Grilled by Senate, PhRMA’s IRA Win and BMS’ KarXT Awaits Approval
New revelations from the showdown between Novo Nordisk’s CEO and Bernie Sanders’ Senate health committee Tuesday; PhRMA’s legal victory in IRA case; the federal interest rate cut and anticipated approval for schizophrenia.
September 25, 2024
·
1 min read
·
Heather McKenzie
Business
Newly Stacked PhRMA to Meet With Trump on IRA, Other Policies
The meeting, which will include Pfizer CEO Albert Bourla as the newly named board of directors’ chair, will reportedly cover key topics for the lobbying group, including the Inflation Reduction Act.
February 20, 2025
·
2 min read
·
Kate Goodwin
Legal
Appeals Court Breathes New Life Into PhRMA’s Legal Challenge to IRA
A lawsuit filed by the Pharmaceutical Research and Manufacturers of America, which claims the Inflation Reduction Act’s Medicare Drug Price Negotiation Program is unconstitutional, now goes back to a lower Texas court.
September 23, 2024
·
2 min read
·
Tristan Manalac
PhRMA, BIO Push Back Against Rare String of Setbacks
The two biopharmaceutical industry organizations entered Medicare price negotiations after the loss of several prominent members and executives.
January 23, 2024
·
4 min read
·
Neil Versel
Policy
Texas Court Dismisses PhRMA IRA Lawsuit Against Biden Administration
On Monday, the Biden administration got an early victory in pharma’s legal challenge to the Inflation Reduction Act, with a Texas judge dismissing a complaint from the Pharmaceutical Research and Manufacturers of America.
February 13, 2024
·
2 min read
·
Tristan Manalac
Policy
PhRMA Loses Another Legal Battle as Court Sides with Arkansas Over Drug Discount Program
A lawsuit filed by the Pharmaceutical Research and Manufacturers of America failed to block an Arkansas law that empowers hospitals to use outside pharmacies to dispense discounted drugs.
March 14, 2024
·
2 min read
·
Tristan Manalac
Policy
PhRMA Names Gilead CEO O’Day as New Board Chair Following Loss of Members
With the departure of AbbVie and AstraZeneca from the trade group, Pharmaceutical Research and Manufacturers of America has named new members to its leadership including Gilead Sciences chief Daniel O’Day.
February 22, 2024
·
2 min read
·
Tristan Manalac
Policy
Industry Group Prepares Another Lawsuit Against Florida’s Drug Importation Plan
Following the FDA’s approval of the program, PhRMA is once again suing to block Florida from importing prescription drugs from Canada.
January 9, 2024
·
2 min read
·
Tristan Manalac
Business
C-Suite Shuffle: ReNAgade, Adaptimmune, Vittoria and More
Plus, last week Richard Gonzalez announced his retirement from AbbVie, PhRMA appointed Gilead’s O’Day to chair its board and Joseph Papa became president and CEO of Emergent.
February 28, 2024
·
5 min read
·
Neil Versel
Policy
PhRMA Joins Merck, BMS in Latest Lawsuit Challenging IRA’s Drug Price Negotiations
On the heels of Merck’s and BMS’ lawsuits, the pharma industry’s lobbying group Wednesday filed a complaint in federal court asserting that the price-setting provisions in the Inflation Reduction Act are unconstitutional.
June 21, 2023
·
2 min read
·
Lisa Munger
1 of 78
Next
